AVROBIO announces merger with Tectonic Therapeutic in significant all-stock deal
AVROBIO, Inc. (Nasdaq: AVRO) and Tectonic Therapeutic, Inc., a biotechnology firm specializing in GPCR (G-protein coupled receptor)-targeted therapeutic proteins, have announced a definitive merger agreement. This all-stock transaction will result in AVROBIO acquiring 100% of Tectonic’s outstanding equity interests, with the merged entity operating under the name Tectonic Therapeutic, Inc. and trading on Nasdaq under […]